All News
Filter News
Found 7,596 articles
-
Pressure Lead Pfizer CEO to Approach Teva Pharmaceutical Industries Limited Late Last Year
1/26/2015
-
With Ties to Eli Lilly, Innovent Biologics Scores $100 Million
1/22/2015
-
European Medicines Agency Accepts Samsung Bioepis' Enbrel® Biosimilar Candidate, SB4, For Regulatory Review
1/21/2015
-
Mitsubishi Gas Forms Asian Biologics CRO Partnership With Catalent
1/21/2015
-
Momenta Pharmaceuticals, Inc. Announces Supreme Court Decision To Remand Generic Copaxone® Case Back To CAFC
1/21/2015
-
GPhA President And CEO Ralph G. Neas To Step Down In The Fall Of 2015
1/21/2015
-
Hospira, Inc. Receives FDA Clearance For Plum 360™ Infusion System
1/20/2015
-
Actavis, Gedeon Richter Ltd. Say Key Drug Cariprazine Effective on Schizophrenia Relapse
1/20/2015
-
Hospira, Inc. to Shutter Plant, 250 Workers Affected
1/20/2015
-
CPhI Worldwide Announces International Advisory Board
1/19/2015
-
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas
1/13/2015
-
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas
1/13/2015
-
Hospira, Inc. Submits New Biologics License Application To U.S. FDA For Proposed Epoetin Alfa Biosimilar
1/12/2015
-
EXCLUSIVE: Developing World Needs Different Pricing Model, Naia Limited CEO Tells BioSpace
1/9/2015
-
FDA Lifts Import Ban on Hospira, Inc.'s Infusion Pumps
1/9/2015
-
FDA Panel Unanimously Backs Novartis AG's Copy of Amgen Drug
1/8/2015
-
Dermira And UCB SA Announce Start Of Phase 3 Program For CIMZIA® (Certolizumab Pegol) In Psoriasis
1/8/2015
-
Biotechnology Industry Organization (BIO) Urges FDA To Release Guidance On Biosimilars
1/7/2015
-
Actavis And Gedeon Richter Ltd. Announce FDA Receipt Of NDA Resubmission For Cariprazine
1/6/2015
-
Fosun Pharma To Double R&D Budget: $800 Million In 2016-2020
1/6/2015